Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



QuantWave Hits 8.22% Profit Target with GSK PLC Stock Forecast

August 27, 2024
QuantWave, the automated forecasting platform, achieved a remarkable success with its prediction for GSK PLC stock. The forecast signal was issued on August 13, 2024, with a price of 39.44 $. The direction predicted was long, and on August 27, 2024, the target price of 42.68 $ was reached, resulting in a profit of 8.22%.

The movement of GSK PLC stock can be attributed to several factors, including positive developments in the company's pipeline, market trends in the pharmaceutical sector, and overall investor sentiment. QuantWave's accurate forecast reflects the platform's advanced analytics and predictive capabilities, providing users with valuable insights for informed decision-making.

QuantWave offers forecasting opportunities for a wide range of stocks, enabling users to potentially capitalize on market movements and generate profits. For a more in-depth understanding of QuantWave's investment strategy, users can explore QuantSchool – a professional investment framework that outlines key principles for maximizing returns using the QuantWave forecasting system.

Find out how the GSK PLC rate is expected to change

Get Forecast for GSK
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for GSK

GSKMay 30, 2025QuantWave Achieves 10.41% Profit Target with GSK PLC Forecast  ~1 min.

On February 28, 2025, QuantWave, the automated forecasting platform, issued a long signal for GSK PLC with a price of $37.16. After a successful prediction, the stock reached the target price of $41....

GSKApril 7, 2025QuantWave Achieves 7.44% Profit Target Forecast for GSK PLC  ~1 min.

On April 2, 2025, QuantWave, the automated forecasting platform, issued a short signal for GSK PLC stock with a price target forecast of $34.44, a 7.44% profit from the signal price of $37.21....

GSKMarch 21, 2025GSK Lead Plaintiff Deadline Approaching - Contact Robbins LLP for Information About How to Lead the GSK PLC Class Action  ~2 min.

GSK PLC, a global pharmaceutical company, is facing a class action lawsuit....

GSKMarch 19, 2025GSK Faces Class Action Lawsuit and Upcoming Deadlines - Investors Beware!  ~2 min.

Global pharmaceutical company, GSK PLC, is currently facing a class action lawsuit, with upcoming deadlines for affected investors to be aware of....

GSKMarch 18, 2025QuantWave Successfully Achieves Price Target Forecast for GSK PLC, Generating 8.28% Profit  ~2 min.

On February 27, 2025, QuantWave, an automated forecasting platform, issued a long signal for GSK PLC with a price target forecast of $39.93. The stock was trading at $36.87 at the time of the signal....



Related news

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....

REGNOctober 31, 2024REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with 16.62% Profit: A Deep Dive into QuantWave's Success  ~1 min.

On October 8, 2024, QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. signaled a short direction with a price of 1002.49 $....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....

REGNAugust 19, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 14.57% Profit Margin  ~1 min.

On July 2nd, 2024, QuantWave issued a forecast signal for REGENERON PHARMACEUTICALS, INC., predicting a long position when the stock was trading at 1041.78 $....